← Back to Screener
Radiopharm Theranostics Limited American Depositary Shares (RADX)
Price$4.64
Favorite Metrics
Price vs S&P 500 (26W)-40.15%
Price vs S&P 500 (4W)-3.53%
Market Capitalization$53.32M
All Metrics
Book Value / Share (Quarterly)$0.01
P/TBV (Annual)2.59x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)-17.08%
Net Profit Margin (TTM)-1236.29%
EPS (TTM)$-0.01
10-Day Avg Trading Volume1.42M
EPS Excl Extra (TTM)$-0.01
EPS (Annual)$-0.01
ROI (Annual)-81.94%
Gross Margin (Annual)1.08%
Cash / Share (Quarterly)$0.01
Revenue Growth QoQ (YoY)0.14%
ROA (Last FY)-42.44%
Revenue Growth TTM (YoY)116.02%
EBITD / Share (TTM)$-0.01
Operating Margin (TTM)-1283.95%
Cash Flow / Share (Annual)$-0.01
P/B Ratio1.44x
P/B Ratio (Quarterly)1.71x
Net Income / Employee (Annual)$-2
EV / Revenue (TTM)10.98x
Net Interest Coverage (TTM)-7.52x
ROA (TTM)-50.60%
EPS Incl Extra (Annual)$-0.01
Current Ratio (Annual)2.67x
Quick Ratio (Quarterly)3.01x
3-Month Avg Trading Volume8.17M
52-Week Price Return-8.70%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.00
P/S Ratio (Annual)20.48x
Asset Turnover (Annual)0.04x
52-Week High$0.04
EPS Excl Extra (Annual)$-0.01
26-Week Price Return-36.36%
Quick Ratio (Annual)2.67x
13-Week Price Return-12.50%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.01x
Enterprise Value$28.591
Asset Turnover (TTM)0.04x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-1052.43%
Cash / Share (Annual)$0.01
3-Month Return Std Dev67.96%
Net Income / Employee (TTM)$-2
ROE (Last FY)-81.94%
Net Interest Coverage (Annual)-6.86x
EPS Basic Excl Extra (Annual)$-0.01
Receivables Turnover (TTM)0.41x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.01
Receivables Turnover (Annual)0.64x
ROI (TTM)-93.08%
P/S Ratio (TTM)20.47x
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.02
Price vs S&P 500 (52W)-38.76%
Year-to-Date Return-16.00%
5-Day Price Return0.00%
EPS Normalized (Annual)$-0.01
ROA (5Y Avg)-328.52%
Net Profit Margin (Annual)-1010.15%
Month-to-Date Return0.00%
EBITD / Share (Annual)$-0.01
Operating Margin (Annual)-1050.63%
EPS Basic Excl Extra (TTM)$-0.01
P/TBV (Quarterly)13.22x
P/B Ratio (Annual)1.16x
Pretax Margin (TTM)-1287.55%
Book Value / Share (Annual)$0.01
Price vs S&P 500 (13W)-12.56%
Beta1.75x
Revenue / Share (TTM)$0.00
ROE (TTM)-93.08%
52-Week Low$0.02
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
RADXRadiopharm Theranostics Limited American Depositary Shares | 20.47x | 116.02% | — | — | $4.64 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Radiopharm Theranostics is an Australian clinical-stage radiotherapeutics company targeting cancer with approximately four licensed platform technologies. The company develops diagnostic and therapeutic solutions across pre-clinical and clinical development stages.